Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001140361-20-017612
Filing Date
2020-08-06
Accepted
2020-08-06 07:35:20
Documents
3
Period of Report
2020-08-06

Document Format Files

Seq Description Document Type Size
1 6-K brhc10014139_6k.htm 6-K 11558
2 EXHIBIT 99.1 brhc10014139_ex99-1.htm EX-99.1 11528
3 image00002.jpg GRAPHIC 3834
  Complete submission text file 0001140361-20-017612.txt   29526
Mailing Address WINZERLAER STR. 2 JENA 2M 07745
Business Address WINZERLAER STR. 2 JENA 2M 07745 49 3641 508180
InflaRx N.V. (Filer) CIK: 0001708688 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38283 | Film No.: 201079842
SIC: 2834 Pharmaceutical Preparations